ETON Earnings & Financial Statements
Eton Pharmaceuticals, Inc.
$55.21
+$0.46(+0.84%)
41
Overall
20
Value
40
Tech
63
Quality
Market Cap
$1.58B
Volume
370.98K
52W Range
$14.27 - $66.37
Target Price
$64.10
ETON earnings and financial statements: Eton Pharmaceuticals, Inc.'s income statement, balance sheet and cash flow statement, annual and quarterly.
ETON Annual Financial Statements
| Fiscal year | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Revenue | $79.95M | $39.01M | $31.64M | $21.25M | $21.83M |
| Cost of revenue | $37.21M | $15.60M | $10.58M | $6.93M | $2.83M |
| Operating income | -$844.0K | -$2.60M | -$1.19M | -$8.26M | -$1.50M |
| EBITDA | $226.0K | -$1.48M | $396.0K | -$6.17M | $157.0K |
| Net income | -$4.60M | -$3.82M | -$936.0K | -$9.02M | -$1.96M |
| EPS (diluted) | $-0.17 | $-0.15 | $-0.04 | $-0.36 | $-0.08 |
| Fiscal year | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Total assets | $92.11M | $76.12M | $31.74M | $25.03M | $27.46M |
| Total liabilities | $65.96M | $51.70M | $16.26M | $11.95M | $9.84M |
| Shareholders’ equity | $26.15M | $24.43M | $15.48M | $13.08M | $17.63M |
| Cash and equivalents | $25.94M | $14.94M | $21.39M | $16.30M | $14.41M |
| Long-term debt | $22.23M | $29.92M | $22.0K | $5.49M | $5.28M |
| Fiscal year | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Operating cash flow | $10.52M | $969.0K | $6.82M | $4.82M | -$4.72M |
| Capital expenditure | -$333.0K | -$10.01M | -$775.0K | -$2.79M | -$3.26M |
| Free cash flow | $10.19M | -$9.04M | $6.04M | $2.03M | -$7.98M |
| A | B | C | D | |
|---|---|---|---|---|
| 1 | Symbol | Price | Change | Vol |
| 2 | ETON | $55.21 | +0.8% | 370.98K |
| 3 | ||||
| 4 | ||||
| 5 | ||||
| 6 |
Get Eton Pharmaceuticals, Inc. Data in Excel
Stream real-time data directly to your spreadsheets
BUY NOW